140 related articles for article (PubMed ID: 12431066)
1. Adenosine 5'-O-(1-boranotriphosphate) derivatives as novel P2Y(1) receptor agonists.
Nahum V; Zündorf G; Lévesque SA; Beaudoin AR; Reiser G; Fischer B
J Med Chem; 2002 Nov; 45(24):5384-96. PubMed ID: 12431066
[TBL] [Abstract][Full Text] [Related]
2. Adenine nucleotide analogues locked in a Northern methanocarba conformation: enhanced stability and potency as P2Y(1) receptor agonists.
Ravi RG; Kim HS; Servos J; Zimmermann H; Lee K; Maddileti S; Boyer JL; Harden TK; Jacobson KA
J Med Chem; 2002 May; 45(10):2090-100. PubMed ID: 11985476
[TBL] [Abstract][Full Text] [Related]
3. Subtype specific internalization of P2Y1 and P2Y2 receptors induced by novel adenosine 5'-O-(1-boranotriphosphate) derivatives.
Tulapurkar ME; Laubinger W; Nahum V; Fischer B; Reiser G
Br J Pharmacol; 2004 Jul; 142(5):869-78. PubMed ID: 15197109
[TBL] [Abstract][Full Text] [Related]
4. Diadenosine and diuridine poly(borano)phosphate analogues: synthesis, chemical and enzymatic stability, and activity at P2Y1 and P2Y2 receptors.
Nahum V; Tulapurkar M; Lévesque SA; Sévigny J; Reiser G; Fischer B
J Med Chem; 2006 Mar; 49(6):1980-90. PubMed ID: 16539385
[TBL] [Abstract][Full Text] [Related]
5. P2Y receptor mediated modulation of insulin release by a novel generation of 2-substituted-5'-O-(1-boranotriphosphate)-adenosine analogues.
Farret A; Filhol R; Linck N; Manteghetti M; Vignon J; Gross R; Petit P
Pharm Res; 2006 Nov; 23(11):2665-71. PubMed ID: 17048117
[TBL] [Abstract][Full Text] [Related]
6. 2-Thioether-5'-O-(1-thiotriphosphate)-adenosine derivatives: new insulin secretagogues acting through P2Y-receptors.
Fischer B; Shahar L; Chulkin A; Boyer JL; Harden KT; Gendron FP; Beaudoin AR; Chapal J; Hillaire-Buys D; Petit P
Isr Med Assoc J; 2000 Jul; 2 Suppl():92-8. PubMed ID: 10909425
[TBL] [Abstract][Full Text] [Related]
7. Boranophosphate isoster controls P2Y-receptor subtype selectivity and metabolic stability of dinucleoside polyphosphate analogues.
Yelovitch S; Camden J; Weisman GA; Fischer B
J Med Chem; 2012 Jan; 55(1):437-48. PubMed ID: 22107038
[TBL] [Abstract][Full Text] [Related]
8. 2-thioether 5'-O-(1-thiotriphosphate)adenosine derivatives as new insulin secretagogues acting through P2Y-Receptors.
Fischer B; Chulkin A; Boyer JL; Harden KT; Gendron FP; Beaudoin AR; Chapal J; Hillaire-Buys D; Petit P
J Med Chem; 1999 Sep; 42(18):3636-46. PubMed ID: 10479295
[TBL] [Abstract][Full Text] [Related]
9. Sp-2-propylthio-ATP-α-B and Sp-2-propylthio-ATP-α-B,β-γ-dichloromethylene are novel potent and specific agonists of the human P2Y₁₁ receptor.
Haas M; Ben-Moshe I; Fischer B; Reiser G
Biochem Pharmacol; 2013 Sep; 86(5):645-55. PubMed ID: 23810430
[TBL] [Abstract][Full Text] [Related]
10. Opposite diastereoselective activation of P2Y1 and P2Y11 nucleotide receptors by adenosine 5'-O-(alpha-boranotriphosphate) analogues.
Ecke D; Tulapurkar ME; Nahum V; Fischer B; Reiser G
Br J Pharmacol; 2006 Oct; 149(4):416-23. PubMed ID: 16953187
[TBL] [Abstract][Full Text] [Related]
11. Identification of hydrolytically stable and selective P2Y(1) receptor agonists.
Eliahu SE; Camden J; Lecka J; Weisman GA; Sévigny J; Gélinas S; Fischer B
Eur J Med Chem; 2009 Apr; 44(4):1525-36. PubMed ID: 18760862
[TBL] [Abstract][Full Text] [Related]
12. Novel modified adenosine 5'-triphosphate analogues pharmacologically characterized in human embryonic kidney 293 cells highly expressing rat brain P2Y(1) receptor: Biotinylated analogue potentially suitable for specific P2Y(1) receptor isolation.
Zündorf G; Schäfer R; Vöhringer C; Halbfinger E; Fischer B; Reiser G
Biochem Pharmacol; 2001 May; 61(10):1259-69. PubMed ID: 11322930
[TBL] [Abstract][Full Text] [Related]
13. Diadenosine 5',5''-(boranated)polyphosphonate analogues as selective nucleotide pyrophosphatase/phosphodiesterase inhibitors.
Eliahu S; Lecka J; Reiser G; Haas M; Bigonnesse F; Lévesque SA; Pelletier J; Sévigny J; Fischer B
J Med Chem; 2010 Dec; 53(24):8485-97. PubMed ID: 21090681
[TBL] [Abstract][Full Text] [Related]
14. Fluorescent N2,N3-epsilon-adenine nucleoside and nucleotide probes: synthesis, spectroscopic properties, and biochemical evaluation.
Sharon E; Lévesque SA; Munkonda MN; Sévigny J; Ecke D; Reiser G; Fischer B
Chembiochem; 2006 Sep; 7(9):1361-74. PubMed ID: 16871613
[TBL] [Abstract][Full Text] [Related]
15. A novel insulin secretagogue based on a dinucleoside polyphosphate scaffold.
Eliahu S; Barr HM; Camden J; Weisman GA; Fischer B
J Med Chem; 2010 Mar; 53(6):2472-81. PubMed ID: 20175517
[TBL] [Abstract][Full Text] [Related]
16. 2-MeS-beta,gamma-CCl2-ATP is a potent agent for reducing intraocular pressure.
Eliahu S; Martín-Gil A; Perez de Lara MJ; Pintor J; Camden J; Weisman GA; Lecka J; Sévigny J; Fischer B
J Med Chem; 2010 Apr; 53(8):3305-19. PubMed ID: 20337495
[TBL] [Abstract][Full Text] [Related]
17. Molecular recognition of modified adenine nucleotides by the P2Y(1)-receptor. 1. A synthetic, biochemical, and NMR approach.
Halbfinger E; Major DT; Ritzmann M; Ubl J; Reiser G; Boyer JL; Harden KT; Fischer B
J Med Chem; 1999 Dec; 42(26):5325-37. PubMed ID: 10639276
[TBL] [Abstract][Full Text] [Related]
18. Effects of divalent cations on the potency of ATP and related agonists in the rat isolated vagus nerve: implications for P2 purinoceptor classification.
Trezise DJ; Bell NJ; Kennedy I; Humphrey PP
Br J Pharmacol; 1994 Oct; 113(2):463-70. PubMed ID: 7834197
[TBL] [Abstract][Full Text] [Related]
19. Ontogeny of P2-purinoceptors in the longitudinal muscle and muscularis mucosae of the rat isolated duodenum.
Brownhill VR; Hourani SM; Kitchen I
Br J Pharmacol; 1997 Sep; 122(2):225-32. PubMed ID: 9313929
[TBL] [Abstract][Full Text] [Related]
20. Molecular recognition in purinergic receptors. 2. Diastereoselectivity of the h-P2Y1-receptor.
Major DT; Nahum V; Wang Y; Reiser G; Fischer B
J Med Chem; 2004 Aug; 47(18):4405-16. PubMed ID: 15317453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
